Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

NCT03075696

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Washington University St Louis, Missouri, United States
  • Mount Sinai Medical Center New York, United States
  • MSKCC New York, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

NCT01849263

Conditions
Grade 3a Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

NCT04414163

Conditions
Extranodal NK/T-cell Lymphoma, Extranodal NK/T-cell Lymphoma, Nasal Type, Lymphoma, +5 more
Locations
  • Chonnam National University Hwasun Hospital Gwangju, South Korea
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Active, Not Recruiting

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

NCT04921787

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Boston University Boston, Massachusetts, United States
  • Hennepin Healthcare Research Institute Minneapolis, Minnesota, United States
  • New York University New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

AG-120 in People With IDH1 Mutant Chondrosarcoma

NCT04278781

Conditions
Chondrosarcoma, Chondrosarcoma, Grade 2, Chondrosarcoma, Grade 3, +14 more
Locations
  • Johns Hopkins Hospital (Data Collection Only) Baltimore, Maryland, United States
  • Columbia University (Specimen Analysis Only) New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University (Data Collection Only) Columbus, Ohio, United States
View Trial Details

Related conditions